CDK2 and cancer: For instance, circ-Foxo3 can form a complex with p21 protein and cyclin-dependent kinases 2 (CDK2), inhibit CDK2 function, block the transformation from the G1 phase to S phase, thereby holding back the proliferation of cancer cells (Cao et al., 2020).